ICU sedation, delirium & recovery

Effects of an online information tool on post-traumatic stress disorder in relatives of intensive care unit patients: a multicenter double-blind, randomized, placebo-controlled trial (ICU-Families-Study)

Intensive Care MedPublished Randomised controlled trial

  • prematurely stopped
  • Recruitment prematurely stopped in February 2020 due to COVID-19

Authors' conclusion

Family members of critically ill patients often have significant PTSD symptoms and online information on critical illness did not result in reduced PTSD symptoms.

Study context

Population
Family members of critically ill intensive care unit (ICU) patients, Austria and Switzerland
Participants
89 members
Comparison
Information website on intensive care vs control website
  • Interventionn = 46
  • Controln = 43reference
Primary endpoint
Mean IES score
Follow-up
≈30 days after inclusion, T1
Methodological detailsmulticentre, double-blind, placebo-controlled
  • Multicentre
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

IES score · ~ 30 days after inclusion (T1)

Intervention

23.9

mean · SD 17.9

Control

24.1

mean · SD 13.5

P = 0.892

Further findings

Website use (clicks)

Website use (clicks) — Total clicks
1386

Clinically relevant post-traumatic stress disorder (PTSD) symptoms at baseline (all participants)

Proportion with clinically relevant PTSD symptoms
50%
Baseline Impact of Event Scale (IES) score (mean ± SD)
27.5 ± 12.7

HADS-D score · T1

Overall HADS-D score (mean ± SD; min. 3, max. 31)
12.2 ± 6.1
Did not differ between groups

Original publication

Effects of an online information tool on post-traumatic stress disorder in relatives of intensive care unit patients: a multicenter double-blind, randomized, placebo-controlled trial (ICU-Families-Study). Intensive Care Med. Published 23 October 2023. doi:10.1007/s00134-023-07215-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.